About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Portland | 279 Studies

Clinical Trials Prostate CancerPortland

Prostate Cancer Clinical Trials in Portland

Find 279 clinical trials for prostate cancer near Portland, Oregon. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 279 trials

CompletedStereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerThis phase I trial studies the side effects and the best dose of stereotactic body radiation therapy in treating patients with breast cancer, non-small cell lung cancer, or…NCT02206334·Birmingham, Alabama and 77 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

SuspendedFeasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the ProstateThis clinical trial tests whether it is feasible to use the OmnEcoil system for transrectal magnetic resonance imaging (MRI) to visualize and biopsy suspicious lesions in the…NCT05362032·Portland, Oregon

CompletedSipuleucel-T as Neoadjuvant Treatment in Prostate CancerThis is an open label, Phase 2 trial of immunotherapy with sipuleucel-T as neoadjuvant treatment in men with localized prostate cancer.NCT00715104·Los Angeles, California and 6 others

TerminatedGVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate CancerThe purpose of this study is to compare the duration of survival between GVAX® immunotherapy for prostate cancer and chemotherapy treatment in patients with prostate cancer who no…NCT00089856·Alabaster, Alabama and 125 others

CompletedPROvenge Treatment and Early Cancer TreatmentThe PROTECT-PROvenge Treatment and Early Cancer Treatment trial was a Phase III trial for patients with hormone sensitive prostate cancer.NCT00779402·Berkeley, California and 17 others

CompletedRandomized Salvage Radiation Therapy Plus Enzalutamide Post ProstatectomyThe primary hypothesis of this study is that outcomes for patients with biochemically recurrent prostate cancer following radical prostatectomy will be improved by the addition of…NCT02203695·Washington D.C., District of Columbia and 8 others

TerminatedEPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPCThis is a Phase 1/2 study of EPI-7386 orally administered in combination with enzalutamide in subjects with mCRPC.NCT05075577·Tucson, Arizona and 23 others

CompletedStudy of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate CancerMulticenter study in which patients with metastatic hormone refractory prostate cancer (HRPC), who have not had previous chemotherapy or immunotherapy treatments, received MDX-010…NCT00323882·Los Angeles, California and 13 others

CompletedCalcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate CancerRATIONALE: Calcitriol may cause prostate cancer cells to look more like normal cells, and to grow and spread more slowly.NCT00182741·Portland, Oregon

RecruitingDocetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponseThis study is being done to answer the following question: can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual combination of drugs?NCT06592924·Anchorage, Alaska and 394 others

CompletedTrial of ARV-110 and Abiraterone in Participants With Metastatic Prostate CancerPhase 1b study to assess the combination of ARV-110 (bavdegalutamide) and abiraterone in participants with metastatic prostate cancer with rising PSA values on abiraterone.NCT05177042·Santa Monica, California and 17 others

RecruitingA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC).NCT06925737·Phoenix, Arizona and 302 others

WithdrawnEfficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate CancerLE-DT is a novel, proprietary delivery system of docetaxel developed by NeoPharm, Inc. Docetaxel (currently marketed as Taxotere) is an anti-microtubular network agent and is one…NCT01188408·Washington D.C., District of Columbia and 1 other

CompletedObservational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)The purpose of this study is to describe patterns of care in CRPC patients, as well as health-related quality of life (HRQoL) outcomes associated with CRPC and its management.NCT02380274·Homewood, Alabama and 147 others

Active not recruitingA Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer ImagingThe primary aim of this study is to determine whether a multi-modal, physician-focused behavioral intervention can improve facility-level guideline-concordant utilization of…NCT03445559·Palo Alto, California and 10 others

CompletedHumidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate CancerThis clinical trial studies the feasibility of simulating forest therapy using humidified wood or fragrant oils, in improving immune cells, like natural killer cells, number and…NCT05012813·Portland, Oregon

CompletedStudy of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate CancerThe primary objective of this study was to compare the two alternate primary endpoints of radiographic progression-free survival (rPFS) and overall survival (OS) in patients with…NCT03511664·Scottsdale, Arizona and 87 others

Active not recruitingA Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryPatients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive disease features will receive salvage radiation therapy and standard androgen…NCT03809000·Gilbert, Arizona and 107 others

RecruitingTreating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingThis phase III trial tests two questions by two separate comparisons of therapies.NCT04423211·Anchorage, Alaska and 340 others

CompletedSafety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific AntigenThis is a multicenter phase 2 open-label single-arm study that will evaluate the safety and efficacy of TAK-700 in patients with castration-resistant prostate cancer (CRPC)…NCT01046916·Ann Arbor, Michigan and 2 others

PreviousPage 5 of 14Next

Other Conditions in Portland

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma